| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.3 |